MICHAEL NAPOLITANO: Open Payments
NPI 1043257249 · BIRDSBORO, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$442 in 20 payments from 10 companies in 2025. Trend: 2023 $84 · 2024 $275 · 2025 $442
Food & beverage: $442
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $106 |
| ABBVIE INC. | 4 | $93 |
| AstraZeneca Pharmaceuticals LP | 4 | $74 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $40 |
| Exact Sciences Corporation | 1 | $29 |
| PFIZER INC. | 1 | $22 |
| Lilly USA, LLC | 1 | $21 |
| Amgen Inc. | 1 | $21 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
| GlaxoSmithKline, LLC. | 1 | $17 |
Products named: AIRSUPRA, Ozempic, UBRELVY, QULIPTA, XIFAXAN, Cologuard Collection Kit, NURTEC ODT, MOUNJARO.
Industry payments across PA — which companies pay providers there.
